Urogen Pharma's market cap is currently ―. The company's EPS TTM is $-4.786; its P/E ratio is -1.83; Urogen Pharma is scheduled to report earnings on May 11, 2023, and the estimated EPS forecast is $-1.26. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	$ 16.10M	$ 16.60M	$ 13.56M	$ 16.17M	$ 11.35M
Gross Profit	$ 14.08M	$ 14.76M	$ 12.04M	$ 14.59M	$ 10.11M
EBIT	$ -22.43M	$ -24.42M	$ -27.79M	$ -19.91M	$ -23.44M
EBITDA	$ -21.99M	$ -23.94M	$ -27.33M	$ -19.46M	$ -22.99M
Net Income Common Stockholders	$ -25.83M	$ -26.69M	$ -28.39M	$ -28.45M	$ -30.21M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 95.91M	$ 111.74M	$ 136.44M	$ 89.14M	$ 106.21M
Total Assets	$ 128.47M	$ 146.14M	$ 165.72M	$ 119.75M	$ 134.60M
Total Debt	$ 73.73M	$ 72.71M	$ 71.07M	$ 398.00K	$ 616.00K
Net Debt	$ -22.18M	$ -39.03M	$ -65.37M	$ -88.74M	$ -105.59M
Total Liabilities	$ 191.76M	$ 187.05M	$ 182.79M	$ 111.33M	$ 103.07M
Stockholders Equity	$ -63.29M	$ -40.91M	$ -17.07M	$ 8.41M	$ 31.54M
Cash Flow	-
Free Cash Flow	$ -17.77M	$ -24.26M	$ -24.02M	$ -20.27M	$ -18.67M
Operating Cash Flow	$ -17.61M	$ -24.20M	$ -24.00M	$ -20.07M	$ -18.48M
Investing Cash Flow	$ -35.49M	$ -151.00K	$ 13.60M	$ 9.13M	$ 10.66M
Financing Cash Flow	$ 1.10M	$ -77.00K	$ 70.74M	$ -32.00K	$ -168.00K

Currency in USD

Urogen Pharma Earnings and Revenue History

Income Statement >

Urogen Pharma Debt to Assets

Balance Sheet >

Urogen Pharma Cash Flow

Cash Flow >

Urogen Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing